603605.CG▲
Proya invests 3.13 million yuan for a 19% stake in BISHENGZHIYAN, and plans to commit 100 million yuan to a 3.1 billion yuan industry fund
Proya's wholly owned subsidiary Proya Hainan Investment Co., Ltd. has invested 3.132114 million yuan to become a new shareholder of Shanghai Kede Biotechnology Co., Ltd., the parent company of the functional skincare brand BISHENGZHIYAN, with a 19% stake. Founder Shi Nuo's shareholding has correspondingly dropped to 47.06%, but he remains the largest shareholder. Proya told 21st Century Business Herald that this transaction is a minority equity investment, does not involve control or consolidation, and BISHENGZHIYAN will continue to operate independently with its founding team leading the brand's development. Kede Biotechnology was established in December 2016 and owns the functional skincare brand BISHENGZHIYAN and the body care brand Eios. According to beauty industry media Qingyan, BISHENGZHIYAN's sales on mainstream e-commerce platforms reached 745 million yuan in 2025, and sales in the first eight months of this year were 669 million yuan, with the full year expected to approach the 1 billion yuan level. On the industrial investment side, Proya Hainan Investment Co., Ltd. plans to invest 100 million yuan to subscribe to limited partnership interests in Ningbo Zhixing Yueheng Venture Capital Partnership, a fund managed by Shanghai Zhenxin Valley Investment Management Co., Ltd. The fund's target total committed capital is 3.1 billion yuan, with an initial total committed capital of 920 million yuan. Proya has previously spent a cumulative 779 million yuan to acquire a 51% controlling stake in Flower Knows. This investment in BISHENGZHIYAN is intended to strengthen its position in the functional skincare sector, which is facing growth pressure.
603605.CG · Capital · Positive Proya invests 3.13M yuan for a 19% minority stake in BISHENGZHIYAN's parent and plans 100M yuan into a 3.1B yuan industry fund, expanding its beauty portfolio.
上海科黛生物科技有限公司 · Capital · Positive Shanghai Kede Biotechnology (BISHENGZHIYAN's parent) receives a 3.13M yuan investment from Proya for a 19% stake, valuing the brand at roughly 16.5M yuan.
珀莱雅(海南)投资有限公司 · Capital · Positive Proya Hainan Investment makes the 3.13M yuan stake purchase and plans a 100M yuan fund subscription, serving as the investment vehicle.
上海正心谷投资管理有限公司 · Capital · Neutral Shanghai Zhenxin Valley Investment Management is named only as the manager of the fund Proya plans to invest in; no direct impact stated.